Name | 1-(4-methylphenyl)sulfonyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine |
---|---|
Synonyms |
1H-Pyrrolo[2,3-b]pyridine, 1-[(4-methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine 1-[(4-Methylbenzene)sulfonyl]-1H-pyrrolo[2,3-b]pyridine-3-boronic acid pinacol ester 1-[(4-Methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 1-Tosyl-7-azaindole-3-boronic acid pinacol ester 3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 572.0±60.0 °C at 760 mmHg |
Molecular Formula | C20H23BN2O4S |
Molecular Weight | 398.284 |
Flash Point | 299.8±32.9 °C |
Exact Mass | 398.147156 |
PSA | 78.80000 |
LogP | 3.96170 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.596 |
Storage condition | -20°C |
HS Code | 2934999090 |
---|
~96% 866545-91-7 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED? Patent: WO2005/95400 A1, 2005 ; Location in patent: Page/Page column 326; 327 ; WO 2005/095400 A1 |
~81% 866545-91-7 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED; TAYLOR, Lori, Kell; SEWELL, Kathryn, Lea; HOOCK, Thomas, Carl Patent: WO2014/74471 A1, 2014 ; Location in patent: Paragraph 0278-0280 ; |
~% 866545-91-7 |
Literature: WO2013/6634 A2, ; |
~% 866545-91-7 |
Literature: WO2013/6634 A2, ; |
~% 866545-91-7 |
Literature: WO2013/6634 A2, ; |
Precursor 6 | |
---|---|
DownStream 1 | |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |